Keyphrases
Taiwan
100%
National Cohort Study
100%
Hepatocellular Carcinoma
100%
Second Primary Cancer
100%
Cancer Inpatients
100%
Hepatocellular Carcinoma Patients
36%
Risk Factors
18%
Chronic Kidney Disease
18%
Survivors
18%
Urinary Bladder Cancer
18%
Hepatocellular Carcinoma Surveillance
18%
National Health Insurance Research Database (NHIRD)
9%
High Incidence
9%
High Risk
9%
ICD-9
9%
Female Patients
9%
Kidney
9%
Old Age
9%
Population-based Study
9%
Bone Tissue
9%
Kidney Cancer
9%
Clinical Manifestations
9%
Male Population
9%
Factors Predicting
9%
Hematological Cancer
9%
Standardized Incidence Ratio
9%
Biliary Tract
9%
Competing-risks Regression Model
9%
Renal Cancer
9%
Surveillance Strategy
9%
Medicine and Dentistry
Cohort Analysis
100%
Hepatocellular Carcinoma
100%
Second Cancer
100%
Cancer Diagnosis
18%
Chronic Kidney Disease
18%
Hepatobiliary System
9%
Bladder Cancer
9%
Kidney Cancer
9%
Bladder
9%
Bone Tissue
9%
Standardized Incidence Ratio
9%
Kidney Cancer
9%
Hematological Cancer
9%
Soft Tissue Cancer
9%
Nursing and Health Professions
Cohort Analysis
100%
Liver Cell Carcinoma
100%
Second Cancer
100%
Chronic Kidney Failure
18%
Cancer Diagnosis
18%
National Health Insurance
9%
Bladder Cancer
9%
Female Patient
9%
Standardized Incidence Ratio
9%
Soft Tissue Cancer
9%
Kidney Cancer
9%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Cohort Study
100%
Second Cancer
100%
Chronic Kidney Failure
18%
Bladder Cancer
9%
Kidney Cancer
9%
Standardized Incidence Ratio
9%
Soft Tissue Cancer
9%